Page last updated: 2024-08-16

ribavirin and Granulocytic Leukemia, Chronic

ribavirin has been researched along with Granulocytic Leukemia, Chronic in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19901 (8.33)18.7374
1990's8 (66.67)18.2507
2000's2 (16.67)29.6817
2010's1 (8.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gong, Y; Len, Y; Naren, D; Shi, F; Shi, R; Yan, T; Yang, X1
Kast, RE1
Atkinson, HD; Bogdanovic, A; Colovic, M; Jankovic, G; Milenkovic, P; Sefer, D; Suvajdzic, N1
Hata, Y; Natsumeda, Y; Weber, G1
Gharehbaghi, K; Jayaram, HN; Jayaram, NH; Krohn, K; Paull, KD; Rieser, J1
Chiba, P; Felzmann, T; Fritzer, M; Pillwein, K; Szekeres, T1
Engeler, GP; Hoffman, R; Jayaram, HN; Kneebone, P; Lapis, E; Paulik, E; Tricot, G; Weber, G; Zhen, W1
Cooney, DA; Goldstein, BM; Jayaram, HN; Marquez, VE; Weber, G; Zhen, W1
Weber, G1
Eble, JN; Hoffman, R; Jayaram, HN; Nagai, M; Natsumeda, Y; Paulik, E; Tricot, G; Weber, G; Zhen, WN1
Bhandal, AK; Carter, DL; Moore, DC; Studzinski, GP1
Hoffman, R; Jayaram, HN; Natsumeda, Y; Tricot, GJ; Weber, G; Yamada, Y; Yamaji, Y1

Reviews

1 review(s) available for ribavirin and Granulocytic Leukemia, Chronic

ArticleYear
Potential for all-trans retinoic acid (tretinoin) to enhance interferon-alpha treatment response in chronic myelogenous leukemia, melanoma, myeloma and renal cell carcinoma.
    Cancer biology & therapy, 2008, Volume: 7, Issue:10

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Carcinoma, Renal Cell; Drug Screening Assays, Antitumor; Hepacivirus; Humans; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Melanoma; Models, Biological; Multiple Myeloma; Ribavirin; Tetrahydronaphthalenes; Treatment Outcome; Tretinoin

2008

Trials

1 trial(s) available for ribavirin and Granulocytic Leukemia, Chronic

ArticleYear
Tiazofurin down-regulates expression of c-Ki-ras oncogene in a leukemic patient.
    Cancer communications, 1991, Volume: 3, Issue:3

    Topics: Adenine Nucleotides; Antimetabolites, Antineoplastic; Blast Crisis; Blotting, Northern; Down-Regulation; Gene Expression Regulation; Genes, ras; Guanosine Triphosphate; Humans; Hypoxanthine; Hypoxanthines; IMP Dehydrogenase; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Pilot Projects; Ribavirin; RNA; Uric Acid

1991

Other Studies

10 other study(ies) available for ribavirin and Granulocytic Leukemia, Chronic

ArticleYear
Ribavirin Inhibits the Activity of mTOR/eIF4E, ERK/Mnk1/eIF4E Signaling Pathway and Synergizes with Tyrosine Kinase Inhibitor Imatinib to Impair Bcr-Abl Mediated Proliferation and Apoptosis in Ph+ Leukemia.
    PloS one, 2015, Volume: 10, Issue:8

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Eukaryotic Initiation Factor-4E; Gene Expression Regulation, Neoplastic; Humans; Imatinib Mesylate; Intracellular Signaling Peptides and Proteins; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; MAP Kinase Signaling System; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Serine-Threonine Kinases; Ribavirin; Signal Transduction; TOR Serine-Threonine Kinases

2015
In vitro sensitivity of hematopoietic progenitors to tiazofurin in refractory acute myeloid leukemia and in the blast crisis of chronic myeloid leukemia.
    Cancer letters, 2003, Jun-10, Volume: 195, Issue:2

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Blast Crisis; Blood Cells; Bone Marrow Cells; Drug Resistance, Neoplasm; Enzyme Inhibitors; Female; Hematopoietic Stem Cells; Humans; Inhibitory Concentration 50; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Male; Middle Aged; Neoplastic Stem Cells; Ribavirin; Tumor Cells, Cultured; Tumor Stem Cell Assay

2003
Tiazofurin decreases Ras-GTP complex in K562 cells.
    Oncology research, 1993, Volume: 5, Issue:4-5

    Topics: Antimetabolites, Antineoplastic; Cell Differentiation; Guanosine; Guanosine Diphosphate; Guanosine Triphosphate; Humans; Hypoxanthine; Hypoxanthines; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Oncogene Protein p21(ras); Protein Binding; Ribavirin; Tumor Cells, Cultured

1993
Cytotoxicity of a new IMP dehydrogenase inhibitor, benzamide riboside, to human myelogenous leukemia K562 cells.
    Biochemical and biophysical research communications, 1992, Aug-14, Volume: 186, Issue:3

    Topics: Antineoplastic Agents; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Humans; IMP Dehydrogenase; Kinetics; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Molecular Structure; Nucleosides; Ribavirin; Ribonucleotides

1992
Cell cycle dependent regulation of IMP dehydrogenase activity and effect of tiazofurin.
    Life sciences, 1992, Volume: 51, Issue:16

    Topics: Antimetabolites, Antineoplastic; Cell Cycle; Guanosine Triphosphate; Humans; IMP Dehydrogenase; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Promyelocytic, Acute; Ribavirin; Tumor Cells, Cultured

1992
Clinical pharmacokinetic study of tiazofurin administered as a 1-hour infusion.
    International journal of cancer, 1992, May-08, Volume: 51, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Blast Crisis; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Ribavirin

1992
Cytotoxicity of tiazofurin and its arabinose and xylose analogues in K562 cells.
    Biochemical and biophysical research communications, 1991, Oct-31, Volume: 180, Issue:2

    Topics: Adenine Nucleotides; Antimetabolites, Antineoplastic; Arabinonucleosides; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Humans; IMP Dehydrogenase; Kinetics; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Nucleosides; Ribavirin

1991
IMP dehydrogenase and GTP as targets in human leukemia treatment.
    Advances in experimental medicine and biology, 1991, Volume: 309B

    Topics: Adult; Aged; Allopurinol; Antineoplastic Agents; Female; Genes, myc; Genes, ras; Guanosine Triphosphate; Humans; IMP Dehydrogenase; In Vitro Techniques; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Ribavirin; Tumor Cells, Cultured

1991
Inhibition by 1,25 dihydroxyvitamin D3 of chemically induced erythroid differentiation of K562 leukemia cells.
    Blood, 1991, Apr-01, Volume: 77, Issue:7

    Topics: Animals; Calcitriol; Cell Differentiation; Cell Division; Cell Line; Cytarabine; Humans; Kinetics; Leukemia, Experimental; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Receptors, Calcitriol; Receptors, Steroid; Ribavirin; RNA, Messenger; Time Factors

1991
IMP dehydrogenase: inhibition by the anti-leukemic drug, tiazofurin.
    Leukemia research, 1989, Volume: 13, Issue:2

    Topics: Adenine Nucleotides; Antineoplastic Agents; Blast Crisis; Female; Humans; IMP Dehydrogenase; Ketone Oxidoreductases; Kinetics; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; NADP; Ribavirin; Ribonucleosides

1989